Circulating tumor cells in breast cancer: Fiction or reality?

Journal of Clinical Oncology

Volumn 26, Issue 21, 2008, Pages 3656-3657

  Cristofanilli, Massimo ^a   Reuben, James ^a   Uhr, Jonathan ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER STEM CELL; CLINICAL PRACTICE; DRUG EFFICACY; EPITHELIUM CELL; HUMAN; LETTER; METASTASIS; MONONUCLEAR CELL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; TUMOR CELL; TUMOR GROWTH; ADJUVANT CHEMOTHERAPY; BLOOD; BREAST TUMOR; DRUG EFFECT; FEMALE; NOTE; PATHOLOGY; TUMOR EMBOLISM;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; NEOPLASM CIRCULATING CELLS;

EID: 49049084491     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.18.0356     Document Type: Letter

References (10)

1. Pachmann K, Camara O, Kavallaris A, et al: Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol 26:1208-1215, 2008
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983-3988, 2003
3. Pierga JY, Bonneton C, Vincent-Salomon A, et al: Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clin Cancer Res 10:1392-1400, 2004
4. Cristofanilli M, Budd GT, Ellis M, Stopeck A, Matera J, Miller MC, et al: Circulating tumor cells predict progression free survival and overall survival in metastatic breast cancer. N Engl J Med 351:781-791, 2004
5. Kuerer HM, Newman LA, Smith TL, et al: Clinical course of breast cancer patients with complete pathological primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17:460-469, 1999
6. Harris L, Fritsche H, Mennel R, et al: American Society of Clinical Oncology 2007 update of recommendations for their use of tumor markers in breast cancer. J Clin Oncol 25:5287-5312, 2007
7. Janni W, Rack B, Schindlbeck C, et al: Persistence of isolated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse. Cancer 103:884-891, 2005
8. Riethdorf S, Fritsche H, Mueller V, et al: Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the CellSearch system. Clin Cancer Res 13:920-928, 2007
9. Fehm T, Morrison L, Saboorian H, et al: Patterns of aneusomy for three chromosomes in individual cells from breast cancer tumors. Breast Cancer Res Treat 75:227-239, 2002
10. Meng S, Tripathy D, Shete S, et al: HER-2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci U S A 101:9393-9398, 2004